Grachev Igor D 4
4 · Cellectar Biosciences, Inc. · Filed Jan 8, 2020
Insider Transaction Report
Form 4
Grachev Igor D
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-01-06+80,000→ 80,000 totalExercise: $2.46Exp: 2030-01-06→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Options vest in equal annual increments over a period of three years from the date of grant.